Abbott India: Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

For grievances: [email protected]